TRDA - Entrada Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$16.00
DETAILS
HIGH:
$21.00
LOW:
$10.00
MEDIAN:
$17.00
CONSENSUS:
$16.00
UPSIDE:
164.46%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-06-10 | Zeiher Bernhardt G | director | A-Award | 19,000 | $5.97 | $113K |
| 2026-06-10 | PARMAR KUSH | director, 10 percent owner: | A-Award | 19,000 | $5.97 | $113K |
| 2026-06-10 | KIM PETER S | director | A-Award | 19,000 | $5.97 | $113K |
| 2026-06-10 | Chapman Gina | director | A-Award | 19,000 | $5.97 | $113K |
| 2026-06-10 | Thistle Mary | director | A-Award | 19,000 | $5.97 | $113K |
| 2026-06-10 | Radhakrishnan Maha | director | A-Award | 19,000 | $5.97 | $113K |
| 2026-05-20 | Zeiher Bernhardt G | director | BUY | 5,000 | $5.86 | $29K |
| 2026-05-04 | Dowden Nathan J | officer: President & COO | SELL | 15,000 | $15.33 | $230K |
| 2026-05-04 | Dowden Nathan J | officer: President & COO | M-Exempt | 15,000 | $1.74 | $26K |
| 2026-05-04 | Sethuraman Natarajan | officer: President, Research & Develop. | SELL | 25,907 | $15.39 | $399K |
| 2026-04-01 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | SELL | 2,500 | $12.95 | $32K |
| 2026-03-10 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | SELL | 11,388 | $13.02 | $148K |
| 2026-03-09 | Dowden Nathan J | officer: President & COO | SELL | 3,116 | $13.02 | $41K |
| 2026-03-10 | Dowden Nathan J | officer: President & COO | SELL | 11,894 | $13.05 | $155K |
| 2026-03-09 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | SELL | 5,089 | $13.00 | $66K |
| 2026-03-04 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | SELL | 7,988 | $12.25 | $98K |
| 2026-03-01 | Doshi Dipal | director, officer: CEO | A-Award | 208,000 | $11.93 | $2.5M |
| 2026-03-03 | Sethuraman Natarajan | officer: President, Research & Develop. | F-InKind | 7,577 | $11.76 | $89K |
| 2026-03-02 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | F-InKind | 2,939 | $11.66 | $34K |
| 2026-03-01 | WENTWORTH KORY JAMES | officer: Chief Financial Officer | A-Award | 66,600 | $11.93 | $795K |
| 2026-03-02 | Sethuraman Natarajan | officer: President, Research & Develop. | F-InKind | 3,898 | $11.66 | $45K |
| 2026-03-03 | Doshi Dipal | director, officer: CEO | F-InKind | 19,181 | $11.76 | $225K |
| 2026-03-02 | Dowden Nathan J | officer: President & COO | F-InKind | 7,223 | $11.66 | $84K |
| 2026-03-03 | Dowden Nathan J | officer: President & COO | F-InKind | 14,038 | $11.76 | $165K |
| 2026-03-01 | Dowden Nathan J | officer: President & COO | A-Award | 83,200 | $11.93 | $993K |